{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:28:51Z","timestamp":1785774531629,"version":"3.56.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.advms.2023.09.010","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T12:28:17Z","timestamp":1696681697000},"page":"386-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Biological, genetic and epigenetic markers in ulcerative colitis"],"prefix":"10.1016","volume":"68","author":[{"given":"Gemma","family":"Caliendo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"D'Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5519-3351","authenticated-orcid":false,"given":"Jasmine","family":"Makker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Passariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Vietri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9853","key":"10.1016\/j.advms.2023.09.010_bib1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.advms.2023.09.010_bib2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ecco-jcc\/jjaa265","article-title":"Predicting outcome in acute severe colitis-controversies in clinical practice in 2021","volume":"15","author":"Gupta","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.32074\/1591-951X-336","article-title":"Very Early Onset-IBD: evidence for the need of a multidisciplinary approach","volume":"114","author":"Parente","year":"2022","journal-title":"Pathologica"},{"issue":"10080","key":"10.1016\/j.advms.2023.09.010_bib4","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.advms.2023.09.010_bib5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.advms.2023.09.010_bib6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.advms.2023.09.010_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00365521.2021.2015801","article-title":"Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis","volume":"57","author":"Dignass","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.advms.2023.09.010_bib8","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.03.001","article-title":"Clinical practice guidelines for the medical management of non hospitalized ulcerative colitis: the Toronto consensus","volume":"148","author":"Bressler","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.advms.2023.09.010_bib9","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2021.07.026","article-title":"Systemic inflammation in preclinical ulcerative colitis","volume":"161","author":"Bergemalm","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/21655979.2020.1863016","article-title":"Characteristics of immune cell infiltration and associated diagnostic biomarkers in ulcerative colitis: results from bioinformatics analysis","volume":"12","author":"Xue","year":"2021","journal-title":"Bioengineered"},{"issue":"3","key":"10.1016\/j.advms.2023.09.010_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.15403\/jgld.2014.1121.273.pti","article-title":"J\u00a0Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis","volume":"27","author":"Rokkas","year":"2018","journal-title":"Gastrointestin Liver Dis"},{"issue":"6","key":"10.1016\/j.advms.2023.09.010_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4291\/wjgp.v6.i1.13","article-title":"Laboratory markers in ulcerative colitis: current insights and future advances","volume":"6","author":"Cioffi","year":"2015","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.advms.2023.09.010_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmed.2020.00123","article-title":"Serum biomarkers for inflammatory bowel disease","volume":"7","author":"Chen","year":"2020","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.advms.2023.09.010_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MPG.0000000000002797","article-title":"Analysis of using the total white blood cell count to define severe new-onset ulcerative colitis in children","volume":"71","author":"Mack","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.advms.2023.09.010_bib16","article-title":"Clinical significance of blood platelets and mean platelet volume in patients with ulcerative colitis","volume":"49","author":"Chen","year":"2021","journal-title":"J\u00a0Int Med Res"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000662","article-title":"Effect of disease duration on the association between serum albumin and mucosal healing in patients with ulcerative colitis","volume":"8","author":"Yagi","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12876-020-01229-8","article-title":"Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission","volume":"20","author":"Wakai","year":"2020","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib19","first-page":"31","article-title":"Serum levels of beta2 microglobulin and ultrasensitive c-reactive protein as markers of histological activity in ulcerative colitis","volume":"146","author":"Yamamoto-Furusho","year":"2010","journal-title":"Gac Med Mex"},{"issue":"32","key":"10.1016\/j.advms.2023.09.010_bib20","first-page":"5191","article-title":"Microheterogeneity of acute phase proteins in patients with ulcerative colitis- World","volume":"12","author":"Grzymis\u0142awski","year":"2006","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.advms.2023.09.010_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9541370","article-title":"Reduced transferrin levels in active inflammatory bowel disease","volume":"2017","author":"Matusiewicz","year":"2017","journal-title":"BioMed Res Int"},{"issue":"2","key":"10.1016\/j.advms.2023.09.010_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3748\/wjg.v27.i2.162","article-title":"Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis","volume":"27","author":"Motooka","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.advms.2023.09.010_bib23","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/CM9.0000000000001390","article-title":"Potential molecular biomarkers used to predict the response to biological therapies in ulcerative colitis","volume":"134","author":"Zhang","year":"2021","journal-title":"Chin Med J"},{"issue":"10","key":"10.1016\/j.advms.2023.09.010_bib24","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/ibd\/izz149","article-title":"Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer","volume":"25","author":"Yao","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2023.09.010_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104835","article-title":"Cytokines in inflammatory bowel diseases - update 2020","volume":"158","author":"Leppkes","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.advms.2023.09.010_bib26","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ibd.22936","article-title":"Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis","volume":"18","author":"Serada","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ecco-jcc\/jjw132","article-title":"Leucine-rich alpha-2 glycoprotein is a serum biomarker of mucosal healing in ulcerative colitis","volume":"11","author":"Shinzaki","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.advms.2023.09.010_bib28","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1007\/s10620-018-5446-0","article-title":"Serum procalcitonin as a potential early predictor of short-term outcomes in acute severe ulcerative colitis","volume":"64","author":"Wu","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"45","key":"10.1016\/j.advms.2023.09.010_bib29","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.3748\/wjg.v23.i45.8008","article-title":"Albumin as a prognostic marker for ulcerative colitis","volume":"23","author":"Khan","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.advms.2023.09.010_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/1076029611405034","article-title":"Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease","volume":"17","author":"Alkim","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"10.1016\/j.advms.2023.09.010_bib31","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1053\/j.gastro.2020.12.004","article-title":"Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis","volume":"160","author":"Galipeau","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2023.09.010_bib32","first-page":"1321","article-title":"[August 2019 \u2013 AWMF-registriernummer: 021\u2013009]","volume":"57","author":"Kucharzik","year":"2019","journal-title":"Z\u00a0Gastroenterol"},{"issue":"11","key":"10.1016\/j.advms.2023.09.010_bib33","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/ibd\/izab059","article-title":"Ultra-high magnification endocytoscopy and molecular markers for defining endoscopic and histologic remission in ulcerative colitis-an exploratory study to define deep remission","volume":"27","author":"Iacucci","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.advms.2023.09.010_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2739\/kurumemedj.MS664009","article-title":"Evaluation of serum calprotectin levels in patients with inflammatory bowel disease","volume":"66","author":"Mori","year":"2021","journal-title":"Kurume Med J"},{"issue":"7","key":"10.1016\/j.advms.2023.09.010_bib35","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000501","article-title":"Predicting ulcerative colitis relapse in clinical remission with fecal immunochemical occult blood test or prostaglandin e-major urinary metabolite","volume":"13","author":"Ishida","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.advms.2023.09.010_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/00365513.2016.1185145","article-title":"Evaluation of biomarkers for ulcerative colitis comparing two sampling methods: fecal markers reflect colorectal inflammation both macroscopically and on a cellular level","volume":"76","author":"Peterson","year":"2016","journal-title":"Scand J Clin Lab Investig"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib37","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1038\/s41467-021-24235-0","article-title":"Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen","volume":"12","author":"Soomro","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.advms.2023.09.010_bib38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.advms.2023.09.010_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s13223-020-00433-1","article-title":"Assessment of clinical activity and severity using serum ANCA and ASCA antibodies in patients with ulcerative colitis","author":"Pang","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.advms.2023.09.010_bib40","series-title":"New serologic markers for inflammatory bowel disease diagnosis","author":"Dotan","year":"2010"},{"issue":"12","key":"10.1016\/j.advms.2023.09.010_bib41","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/ibd.20226","article-title":"IBD serological panels: facts and perspectives","volume":"13","author":"Peyrin-Biroulet","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2023.09.010_bib42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/gast.2002.35379","article-title":"Selected loss of tolerance evidenced by Crohn's disease associated immune responses to auto- and microbial antigens","volume":"123","author":"Landers","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2023.09.010_bib43","series-title":"Serum antibodies associated with complex inflammatory bowel disease","author":"Elkadri","year":"2013"},{"issue":"12","key":"10.1016\/j.advms.2023.09.010_bib44","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s10620-005-3056-0","article-title":"Pancreatic autoantibodies in Greek patients with inflammatory bowel disease","volume":"50","author":"Koutroubakis","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.advms.2023.09.010_bib45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00054725-200409000-00016","article-title":"Serum p53 antibodies in patients affected with ulcerative colitis","volume":"10","author":"Cioffi","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.advms.2023.09.010_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ibd.20112","article-title":"Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis","volume":"13","author":"Yoshizawa","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.advms.2023.09.010_bib47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/MEG.0000000000001490","article-title":"Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis","volume":"31","author":"Kourkoulis","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.advms.2023.09.010_bib48","first-page":"788","article-title":"Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis","volume":"23","author":"Nakov","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.advms.2023.09.010_bib49","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1097\/MIB.0000000000000938","article-title":"Fecal HMGB1 reveals microscopic inflammation in adult and pediatric patients with inflammatory bowel disease in clinical and endoscopic remission","volume":"22","author":"Palone","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2023.09.010_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-016-0520-6","article-title":"Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution","volume":"16","author":"D\u00edaz-Jim\u00e9nez","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.advms.2023.09.010_bib51","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.4049\/jimmunol.0800933","article-title":"B\u00a0cell receptor and BAFF receptor signaling regulation of B cell homeostasis","volume":"183","author":"Khan","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.advms.2023.09.010_bib52","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000000837","article-title":"Fecal matrix metalloprotease-9 and lipocalin- 2 as biomarkers in detecting endoscopic activity in patients with inflammatory bowel diseases","volume":"52","author":"Buisson","year":"2018","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.advms.2023.09.010_bib53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.advms.2020.03.004","article-title":"Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children","volume":"65","author":"Iwa\u0144czak","year":"2020","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.advms.2023.09.010_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ecco-jcc\/jjv005","article-title":"The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases","volume":"9","author":"Farkas","year":"2015","journal-title":"J.\u00a0Crohn\u2019s Colitis"},{"issue":"9","key":"10.1016\/j.advms.2023.09.010_bib55","first-page":"2655","article-title":"Are matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 useful as markers in diagnostic management of children with newly diagnosed ulcerative colitis?","volume":"11","author":"Czajkowska","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.advms.2023.09.010_bib56","first-page":"1","article-title":"Expression of MMP-2, MMP-7, MMP-9, and TIMP-1 by inflamed mucosa in the initial diagnosis of ulcerative colitis as a response marker for conventional medical treatment","author":"Eiro","year":"2022","journal-title":"Pathobiology"},{"issue":"2","key":"10.1016\/j.advms.2023.09.010_bib57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000456071","article-title":"Serum-derived hyaluronan-associated protein is a novel biomarker for inflammatory bowel diseases","volume":"95","author":"Yamaguchi","year":"2017","journal-title":"Digestion"},{"key":"10.1016\/j.advms.2023.09.010_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235358","article-title":"Which salivary components can differentiate metabolic obesity?","volume":"15","author":"Ostrowska","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12020-015-0777-5","article-title":"Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes","volume":"53","author":"Bellastella","year":"2016","journal-title":"Endocrine"},{"issue":"6 Pt 1","key":"10.1016\/j.advms.2023.09.010_bib60","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/clinchem\/46.6.863","article-title":"Serum concentrations of intact parathyroid hormone in healthy children","volume":"46","author":"Cioffi","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.advms.2023.09.010_bib61","first-page":"425","article-title":"Increased expression of interleukin-6 and tumor necrosis factor alpha in saliva of patients with dental caries and Crohn's disease","volume":"75","author":"Szczeklik","year":"2018","journal-title":"Przegl Lek"},{"key":"10.1016\/j.advms.2023.09.010_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.818902","article-title":"Gut microbiota is a potential biomarker in inflammatory bowel disease","volume":"8","author":"Guo","year":"2022","journal-title":"Front Nutr"},{"issue":"22","key":"10.1016\/j.advms.2023.09.010_bib63","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.3390\/ijms21228562","article-title":"Salivary stress\/immunological markers in Crohn's disease and ulcerative colitis","volume":"21","author":"Finamore","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.advms.2023.09.010_bib64","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ajg.2015.50","article-title":"Familial risk of inflammatory bowel disease: a population-based cohort study 1977\u20132011","volume":"110","author":"Moller","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"7662","key":"10.1016\/j.advms.2023.09.010_bib65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature22969","article-title":"Fine-mapping inflammatory bowel disease loci to single-variant resolution","volume":"547","author":"Huang","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.advms.2023.09.010_bib66","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ng.3176","article-title":"High-density mapping of the MHC identifies a shared role for HLA-DRB1\u221701:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis","volume":"47","author":"Goyette","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.advms.2023.09.010_bib67","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.05.048","article-title":"HLA-Cw\u22171202-B\u22175201-DRB1\u22171502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease","author":"Okada","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.advms.2023.09.010_bib68","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2011.240978","article-title":"Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis","volume":"61","author":"M\u00e1rquez","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.advms.2023.09.010_bib69","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00011-008-8265-5","article-title":"Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population","volume":"58","author":"Marrakchi","year":"2009","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2004.05.015","article-title":"Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis","volume":"95","author":"Yamamoto-Furusho","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.advms.2023.09.010_bib71","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3748\/wjg.v13.i15.2205","article-title":"No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A\/G polymorphisms with Crohn's disease and ulcerative colitis in Hungarian population samples","volume":"13","author":"Magyari","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.advms.2023.09.010_bib72","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1053\/j.gastro.2008.10.032","article-title":"Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship","volume":"136","author":"Anderson","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2023.09.010_bib73","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/ng1339","article-title":"Functional variants of OCTN cation transporter genes are associated with Crohn disease","volume":"36","author":"Peltekova","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.advms.2023.09.010_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.MIB.0000194184.92671.78","article-title":"MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients","volume":"12","author":"Urcelay","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2023.09.010_bib75","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clim.2004.03.002","article-title":"Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis","volume":"112","author":"T\u00f6r\u00f6k","year":"2004","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.advms.2023.09.010_bib76","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng.3761","article-title":"Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7","volume":"49","author":"Luo","year":"2017","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.advms.2023.09.010_bib77","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3109\/10799893.2014.975248","article-title":"Association of vitamin D receptor gene polymorphisms with the susceptibility to ulcerative colitis in patients from Southeast China","volume":"35","author":"Xia","year":"2015","journal-title":"J\u00a0Recept Signal Transduct Res"},{"issue":"8","key":"10.1016\/j.advms.2023.09.010_bib78","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/ibd.21541","article-title":"HNF4 alpha and CDH1 are associated with ulcerative colitis in a Dutch cohort","volume":"17","author":"van Sommeren","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2023.09.010_bib79","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/ng.483","article-title":"Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region","volume":"41","author":"UK IBD Genetics Consortium","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.advms.2023.09.010_bib80","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.48.3.367","article-title":"Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer","volume":"48","author":"Wheeler","year":"2001","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.advms.2023.09.010_bib81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/gtmb.2008.0088","article-title":"I219V polymorphism in hMLH1 gene in patients affected with ulcerative colitis","volume":"13","author":"Vietri","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"issue":"6","key":"10.1016\/j.advms.2023.09.010_bib82","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00535-007-2026-z","article-title":"p53 codon 72 polymorphism in patients affected with ulcerative colitis","volume":"42","author":"Vietri","year":"2007","journal-title":"J\u00a0Gastroenterol"},{"issue":"2","key":"10.1016\/j.advms.2023.09.010_bib83","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000519559","article-title":"Expression of oncogenic molecules in pediatric ulcerative colitis","volume":"103","author":"Arai","year":"2022","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.advms.2023.09.010_bib84","first-page":"513","article-title":"Arg72Pro polymorphism of p53 may predict poor response to medical treatment in ulcerative colitis","volume":"85","author":"Vietri","year":"2014","journal-title":"Ann Ital Chir"},{"key":"10.1016\/j.advms.2023.09.010_bib85","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.01.016","article-title":"Mucosal expression of type 2 and type 17 immune response genes distinguishes ulcerative colitis from colon-only Crohn's disease in treatment-naive pediatric patients","volume":"152","author":"Rosen","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2023.09.010_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013085","article-title":"Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis","author":"Kabakchiev","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.advms.2023.09.010_bib87","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/gutjnl-2019-318343","article-title":"A\u00a0blood-based prognostic biomarker in IBD","volume":"68","author":"Biasci","year":"2019","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.advms.2023.09.010_bib88","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.ajhg.2021.07.013","article-title":"Stratification of risk of progression to colectomy in ulcerative colitis via measured and predicted gene expression","volume":"108","author":"Mo","year":"2021","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.advms.2023.09.010_bib89","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/biom11101440","article-title":"Immunoprofiles and DNA methylation of inflammatory marker genes in ulcerative colitis-associated colorectal tumorigenesis","volume":"11","author":"M\u00e4ki-Nevala","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.advms.2023.09.010_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840935","article-title":"Epigenetic signatures discriminate patients with primary sclerosing cholangitis and ulcerative colitis from patients with ulcerative colitis","volume":"13","author":"de Krijger","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.advms.2023.09.010_bib91","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/ibd.22942","article-title":"Mucosal genome-wide methylation changes in inflammatory bowel disease","volume":"18","author":"Cooke","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2023.09.010_bib92","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3389\/fgene.2019.01017","article-title":"From genetics to epigenetics, roles of epigenetics in inflammatory bowel disease","volume":"10","author":"Zeng","year":"2019","journal-title":"Front Genet"},{"issue":"5","key":"10.1016\/j.advms.2023.09.010_bib93","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2217\/epi-2016-0006","article-title":"A\u00a0systematic review of the role of DNA methylation on inflammatory genes in ulcerative colitis","volume":"8","author":"Gould","year":"2016","journal-title":"Epigenomics"},{"issue":"10","key":"10.1016\/j.advms.2023.09.010_bib94","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.3390\/ijms22105329","article-title":"Epigenetic DNA methylation of EBI3 modulates human interleukin-35 formation via NFkB signaling: a promising therapeutic option in ulcerative colitis","volume":"22","author":"Wetzel","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.advms.2023.09.010_bib95","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.3390\/ijms21217893","article-title":"MicroRNA biomarkers in IBD-differential diagnosis and prediction of colitis-associated cancer","volume":"21","author":"James","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.advms.2023.09.010_bib96","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.3390\/ijms23147991","article-title":"MicroRNAs as innovative biomarkers for inflammatory bowel disease and prediction of colorectal cancer","volume":"23","author":"Masi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.advms.2023.09.010_bib97","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1053\/j.gastro.2008.07.068","article-title":"MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha","volume":"135","author":"Wu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2023.09.010_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104892","article-title":"Genetics and epigenetics of IBD","volume":"159","author":"Annese","year":"2020","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.advms.2023.09.010_bib99","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/2211-5463.13357","article-title":"Integrative computational approach identifies immune-relevant biomarkers in ulcerative colitis","volume":"12","author":"He","year":"2022","journal-title":"FEBS Open Bio"},{"issue":"8","key":"10.1016\/j.advms.2023.09.010_bib100","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3390\/healthcare10081476","article-title":"Artificial intelligence analysis of ulcerative colitis using an autoimmune discovery transcriptomic panel","volume":"10","author":"Carreras","year":"2022","journal-title":"Healthcare (Basel)"},{"issue":"8","key":"10.1016\/j.advms.2023.09.010_bib101","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/gutjnl-2019-320065","article-title":"Big data in IBD: big progress for clinical practice","volume":"69","author":"SeyedTabib","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.advms.2023.09.010_bib102","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.advms.2019.12.009","article-title":"Metabolomic profiling in children with inflammatory bowel disease","volume":"65","author":"Filimoniuk","year":"2020","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.advms.2023.09.010_bib103","article-title":"Investigation of potential genetic biomarkers and molecular mechanism of ulcerative colitis utilizing bioinformatics analysis","volume":"2020","author":"Zhang","year":"2020","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.advms.2023.09.010_bib104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ibd\/izx007","article-title":"Predicting hospitalization and outpatient corticosteroid use in inflammatory bowel disease patients using machine learning","volume":"24","author":"Waljee","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2023.09.010_bib105","doi-asserted-by":"crossref","first-page":"i69","DOI":"10.1093\/bioinformatics\/btu272","article-title":"Robust clinical outcome prediction based on Bayesian analysis of transcriptional profiles and prior causal networks","volume":"30","author":"Zarringhalam","year":"2014","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.advms.2023.09.010_bib106","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","article-title":"AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis","volume":"164","author":"Singh","year":"2023","journal-title":"Gastroenterology"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:44:51Z","timestamp":1761824691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112623000378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1896112623000378"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2023.09.010","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological, genetic and epigenetic markers in ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2023.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}